arrow
A

Anthony Letai

Dana-Farber Cancer Institute
H指数:84
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms

药物耐受性持久细胞和免疫疗法持久细胞表现出交叉耐药性,并共享共同的生存机制。

2025-12-260
PRE
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma

联合MCL-1抑制剂和CD37靶向嵌合抗原受体T细胞作为靶向T细胞淋巴瘤的有效策略

Leukemia
IF13.4
2025-07-300
OA
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts
2024-05-012
OA
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML
2024-02-165
OAAI
Heterogeneity and transcriptional drivers of triple-negative breast cancer
2023-12-015
OAAI
Collateral deletion of the mitochondrial AAA plus ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction

线粒体AAA加ATPase ATAD1的附带缺失使癌细胞对蛋白酶体功能障碍敏感

2022-11-217
OA
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia
2022-05-0929
OAAI